---
title: "Undervalued healthcare stocks with attractive valuation grades"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/299081544.md"
description: "Seeking Alpha highlights 11 undervalued healthcare stocks based on quantitative Valuation Grades. Led by Centene (CNC), Harmony Biosciences (HRMY), and Pfizer (PFE) with A+ grades, the list includes BioCryst (BCRX), Cigna (CI), CVS Health (CVS), and Molina Healthcare (MOH) at A grades. Alignment Healthcare (ALHC), Bristol-Myers Squibb (BMY), DaVita (DVA), and Tenet Healthcare (THC) hold A- grades. These rankings assess stock expensiveness relative to fundamentals, identifying potential investment opportunities in managed care, pharma, and biotech sectors."
datetime: "2026-09-15T17:28:09.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/299081544.md)
  - [en](https://longbridge.com/en/news/299081544.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/299081544.md)
generator: "portal-rs"
---

# Undervalued healthcare stocks with attractive valuation grades

Healthcare stocks continue to attract investor attention as managed care providers, pharmaceutical companies, biotechnology firms and healthcare services businesses navigate changing demand and industry conditions. With valuations varying significantly across the sector, stocks trading at discounts to their underlying fundamentals can offer potenti...

### Related Stocks

- [ALHC.US](https://longbridge.com/en/quote/ALHC.US.md)
- [PFE.US](https://longbridge.com/en/quote/PFE.US.md)
- [BCRX.US](https://longbridge.com/en/quote/BCRX.US.md)
- [CI.US](https://longbridge.com/en/quote/CI.US.md)
- [HRMY.US](https://longbridge.com/en/quote/HRMY.US.md)
- [THC.US](https://longbridge.com/en/quote/THC.US.md)
- [BMY.US](https://longbridge.com/en/quote/BMY.US.md)
- [DVA.US](https://longbridge.com/en/quote/DVA.US.md)
- [MOH.US](https://longbridge.com/en/quote/MOH.US.md)
- [CNC.US](https://longbridge.com/en/quote/CNC.US.md)
- [CVS.US](https://longbridge.com/en/quote/CVS.US.md)

## Related News & Research

- [Pfizer Is Down 34% Over the Last 5 Years. Here's Why Its 6% Dividend Yield Might Finally Be Worth the Risk.](https://longbridge.com/en/news/300770330.md)
- [Florida Attorney General Sues Pfizer for 'Misleading' COVID-19 Vaccine Safety Claims](https://longbridge.com/en/news/300961499.md)
- [What You Could Reuse From Bristol Myers Squibb's 46% Gain](https://longbridge.com/en/news/300610253.md)
- [Bristol Myers Squibb Now Trades at Only 9.4X Forward Earnings -- Is This Value Stock a Buy?](https://longbridge.com/en/news/300852149.md)
- [Evercore ISI Remains a Buy on CVS Health (CVS)](https://longbridge.com/en/news/300802351.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**